The nation of Zimbabwe has turned down a major US healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to the United States' demand for confidential biological samples.
This move was revealed after a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the arrangement was "skewed".
A government spokesman later stated that the United States was requesting health data for research and commercial purposes while refused to share the resulting advantages from future treatments.
"We will now turn to the challenging and unfortunate process of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had provided more than $1.9bn in health funding to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for more dialogue to reach a deal acceptable to all parties so the nation's critical HIV programme can continue.
Broader Implications
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a high court halted a similar deal with the US following legal challenges were raised about the security of Kenyans' health data.
Since resuming office recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had administered assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to enhance openness and responsibility.
Based on reports, Sixteen African countries have so far agreed to similar agreements, representing more than $18.3bn in committed funds.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million presently on HIV treatment through American-funded initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data for a long time, without any equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"Put simply, our country would supply the raw materials for scientific discovery without any assurance that the resulting innovations would be available to our population if a future pandemic emerge."
Sovereignty and Global Health
He also noted that the American exit from the global health body and its pursuit of one-on-one health agreements were undermining structures already set up via the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to manage potential pandemics.
"This framework is intended to guarantee that when a nation provides its samples, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to create them."
The government's concerns over the US deal "are not meant as anti-American sentiment," he added.
"We encourage further discussions with our American counterparts on how future co-operation might be structured in a manner that respects the sovereignty and dignity of each country."
Health Experts Response
Medical experts stated it acknowledged the official position, but recommended that negotiations should continue considering a large portion of the country's Aids initiatives were funded by external financing.
"If specific concerns exist, such as those relating to information security or agreement terms, these can frequently be resolved via technical clarification and mutually agreed protections," it said.
The halted deal highlights the complex tensions between receiving vital foreign assistance and protecting local interests in an ever more interconnected world.